SOT 2016 Annual Meeting and ToxExpo

The SOT Annual Meeting is the largest meeting of its kind. This annual event features a broad range of scientific sessions and a thematic program that provides participants with a unique opportunity to deepen their knowledge in topical areas and interact with leaders in their respective disciplines. The scientific program includes Plenary Lectures and other featured sessions, Symposia, Workshops, Roundtable discussions, Informational Sessions, and a Regional Interest Session, as well as Platform and Poster Sessions. The Society anticipates that more than 6,500 toxicologists from more than 50 countries will attend. The SOT Annual Meeting also includes the ToxExpo, which is the largest exhibition dedicated to toxicology and the biomedical sciences. ToxExpo features 350 exhibitors who lead the industry in developing cutting-edge products, services, and technology to benefit the toxicology community. Exhibitors also have the opportunity to demonstrate their products and educate attendees about their services via Exhibitor-Hosted Sessions throughout the week.

Schedule

17 March

9:30 to 9:40

A Oviedo

Toxicological characterization of the mentholated heat-not-burn product THS2.2M in a 90-day OECD inhalation study

17 March

11:00 to 11:15

B Phillips

Systems toxicological evaluation of a heat-not-burn tobacco product in a 90-day OECD inhalation study in comparison to cigarette smoke

17 March

11:15 to 11:30

B Phillips

Systems toxicology analysis of cardiovascular and respiratory endpoints from ApoE-/- mice showed similar effects when switching to a candidate modified risk tobacco product, THS2.2 or ceasing smoking

17 March

11:30 to 11:40

I Gonzalez-Suarez

System toxicology assessment of a candidate modified risk tobacco product compared to a combustible cigarette

Coming soon

17 March

11:40 to 11:50

N Sierro

Epigenetic changes observed after exposure to a potential Reduced Risk Product, Tobacco Heating System 2.2, in the lung of ApoE-/- mouse

Coming soon

17 March

11:50 to 12:00

S Constant

Evaluation of the stability of reconstituted human bronchial epithelium, MucilAirâ„¢, during 4 weeks in culture

Coming soon

17 March

12:00 to 12:10

E T Wong

Lung inflammation and toxicological assessment in A/J mice in response to chronic exposure to mainstream aerosol from a candidate modified risk tobacco product and smoke from conventional cigarettes

Coming soon

17 March

12:10 to 12:20

A Iskandar

Xenobiotic metabolism responses of nasal, oral and bronchial organotypic epithelial cultures: A comparison of Tobacco Heating System aerosol and cigarette smoke

Coming soon

17 March

12:20 to 12:30

S Frentzel

Cilia of human MucilAirTM are less impacted by the exposure to the aerosol of a candidate modified risk tobacco product than to whole smoke from conventional cigarettes in vitro